Yestar Healthcare Holdings Company Limited (HKG:2393)
0.0650
-0.0030 (-4.41%)
Oct 22, 2026, 3:33 PM HKT
HKG:2393 Revenue
Yestar Healthcare Holdings Company had revenue of 661.61M CNY in the half year ending June 30, 2026, a decrease of -48.06%. This brings the company's total for the last twelve months to 1.35B, down -30.42% year-over-year. In the year 2025, Yestar Healthcare Holdings Company had annual revenue of 1.49B, down -38.17%. That makes Yestar Healthcare Holdings Company the 17,520th largest company in the world by revenue and 1,014th in Hong Kong.
Revenue (ttm)
1.35B CNY
Revenue Growth
-30.42%
P/S Ratio
0.10
Revenue / Employee
3.37M CNY
Employees
400
Market Cap
151.55M HKD
Revenue by Segment
- Medical Products and Equipment 1.32B 88.7%
- Imaging Printing Products 168.36M 11.3%
Fiscal year ended Dec 31, 2025 See the full HKG:2393 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.49B | -919.89M | -38.17% |
| Dec 31, 2024 | 2.41B | -502.82M | -17.26% |
| Dec 31, 2023 | 2.91B | 108.21M | 3.86% |
| Dec 31, 2022 | 2.80B | -2.13B | -43.12% |
| Dec 31, 2021 | 4.93B | 823.75M | 20.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.91B |
| Austar Lifesciences | 1.86B |
| Gaush Meditech | 1.53B |
| Vincent Medical Holdings | 964.90M |
| Acotec Scientific Holdings | 721.55M |
| MicroPort CardioFlow Medtech | 444.00M |
| Suzhou Basecare Medical Corporation | 300.95M |
| Venus Medtech (Hangzhou) | 294.56M |